May 28, 2026 · Form 4 insider transaction
Moss Gregory S. bought 14,223 shares of Evommune, Inc. at $1.71 per share, a transaction worth $24.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 26, 2026.